Erle Refsum

Years Active: 2021-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Jingru Yu, Erle Refsum, Paulina Wieszczy, Lise M Helsingen, Vera Perrin, Amanda Högdén, Magnus Løberg, Johannes Blom, Michael Bretthauer, Hans-Olov Adami, Weimin Ye, Mette Kalager
Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study. BMJ open gastroenterology 10 (1) (2023)
Jingru Yu, Erle Refsum, Paulina Wieszczy, Lise M Helsingen, Vera Perrin, Amanda Högdén, Magnus Løberg, Johannes Blom, Michael Bretthauer, Hans-Olov Adami, Weimin Ye, Mette Kalager
Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study. BMJ open gastroenterology 10 (1) (2023)
Jingru Yu, Erle Refsum, Lise M Helsingen, Trine Folseraas, Alexander Ploner, Paulina Wieszczy, Ishita Barua, Henriette C Jodal, Espen Melum, Magnus Løberg, Johannes Blom, Michael Bretthauer, Hans-Olov Adami, Mette Kalager, Weimin Ye
Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study. United European gastroenterology journal 10 (2) (2022)
Henriette C Jodal, Dagmar Klotz, Magnhild Herfindal, Ishita Barua, Petter Tag, Lise M Helsingen, Erle Refsum, Øyvind Holme, Hans-Olov Adami, Michael Bretthauer, Mette Kalager, Magnus Løberg
Long-term colorectal cancer incidence and mortality after adenoma removal in women and men. Alimentary pharmacology & therapeutics (2021)

Erle Refsum.css-eqlu8i{font-size:small;padding-left:4px;}